Reverting estrogen-receptor-negative phenotype in HER-2-overexpressing advanced breast cancer patients exposed to trastuzumab plus chemotherapy

INTRODUCTION: The amounts of estrogen receptor (ER) and progesterone receptor (PgR) in a primary tumor are predictive of the response to endocrine therapies of breast cancer. Several patients with ER-positive primary tumors relapse after adjuvant endocrine therapy with no ER expression in the recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Munzone, Elisabetta, Curigliano, Giuseppe, Rocca, Andrea, Bonizzi, Giuseppina, Renne, Giuseppe, Goldhirsch, Aron, Nolè, Franco
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413988/
https://www.ncbi.nlm.nih.gov/pubmed/16417653
http://dx.doi.org/10.1186/bcr1366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413988/
https://www.ncbi.nlm.nih.gov/pubmed/16417653
http://dx.doi.org/10.1186/bcr1366

Ejemplares similares